CD274 (Durvalumab Biosimilar) antibody (PE)
-
- Target See all CD274 (Durvalumab Biosimilar) products
- CD274 (Durvalumab Biosimilar)
- Reactivity
- Human
-
Host
-
Humanized
-
Clonality
- Monoclonal
-
Conjugate
- This CD274 (Durvalumab Biosimilar) antibody is conjugated to PE
- Application
- Flow Cytometry (FACS)
- Purpose
- PE-conjugated Anti-PDL1 (durvalumab biosimilar) mAb
- Isotype
- IgG1, K97R, L117F, L118E, P214S
-
-
- Application Notes
- 1 μL:test
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
- Liquid,PBS with 0.05 % Proclin300, 1 % BSA
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage Comment
- Store at 2°C-8°C for 6 months
-
- Target
- CD274 (Durvalumab Biosimilar)
- Alternative Name
- durvalumab Biosimilar (CD274 (Durvalumab Biosimilar) Products)
- Target Type
- Biosimilar
- Background
-
Synonyms Target:PD-L1,CD274,B7-H1,PDCD1L1,PDCD1LG1
Synonyms Antibody:MEDI4736
-